- Home
- LBPH vs SFL Comparison
LBPH vs SFL Comparison
Compare LBPH & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBPH
- SFL
- Stock Information
- Founded
- LBPH 2020
- SFL 2003
- Country
- LBPH United States
- SFL Bermuda
- Employees
- LBPH N/A
- SFL N/A
- Industry
- LBPH Biotechnology: Pharmaceutical Preparations
- SFL Marine Transportation
- Sector
- LBPH Health Care
- SFL Consumer Discretionary
- Exchange
- LBPH Nasdaq
- SFL Nasdaq
- Market Cap
- LBPH 1.4B
- SFL 1.7B
- IPO Year
- LBPH 2021
- SFL N/A
- Fundamental
- Price
- LBPH $59.81
- SFL $10.89
- Analyst Decision
- LBPH Buy
- SFL Strong Buy
- Analyst Count
- LBPH 8
- SFL 1
- Target Price
- LBPH $52.29
- SFL $16.00
- AVG Volume (30 Days)
- LBPH 834.8K
- SFL 916.2K
- Earning Date
- LBPH 11-07-2024
- SFL 11-06-2024
- Dividend Yield
- LBPH N/A
- SFL 9.90%
- EPS Growth
- LBPH N/A
- SFL 39.68
- EPS
- LBPH N/A
- SFL 1.10
- Revenue
- LBPH N/A
- SFL $876,068,000.00
- Revenue This Year
- LBPH N/A
- SFL $20.56
- Revenue Next Year
- LBPH N/A
- SFL N/A
- P/E Ratio
- LBPH N/A
- SFL $9.69
- Revenue Growth
- LBPH N/A
- SFL 19.50
- 52 Week Low
- LBPH $3.60
- SFL $10.01
- 52 Week High
- LBPH $59.95
- SFL $14.62
- Technical
- Relative Strength Index (RSI)
- LBPH 78.81
- SFL 55.01
- Support Level
- LBPH $59.47
- SFL $10.01
- Resistance Level
- LBPH $59.85
- SFL $11.18
- Average True Range (ATR)
- LBPH 0.20
- SFL 0.29
- MACD
- LBPH -0.84
- SFL 0.08
- Stochastic Oscillator
- LBPH 86.36
- SFL 75.21
About LBPH Longboard Pharmaceuticals Inc.
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.
About SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship owning and chartering company. The company is engaged primarily in the ownership and operation of vessels and offshore related assets and is also involved in the charter, purchase, and sale of assets. Its oil tankers, chemical tankers, and oil product tankers are all double-hull vessels.